Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,430 |
|
|||||
| News | - | ||||||
| Day High | 4.48 | Low High |
|||||
| Day Low | 4.2501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Edesa Biotech Inc | EDSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.09 | 2.06% | 4.45 | 17:18:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.35 | 4.2501 | 4.48 | 4.45 | 4.36 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 116 | 2,430 | $ 4.36 | $ 10,605 | - | 2.4603 - 8.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:47:11 | 1 | $ 4.90 | USD |
Edesa Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.11M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Edesa Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.48 | 4.6424 | 4.12 | 4.31 | 4,112 | -0.03 | -0.67% |
| 1 Month | 4.02 | 4.9566 | 3.93 | 4.40 | 7,587 | 0.43 | 10.70% |
| 3 Months | 4.67 | 5.99 | 3.88 | 4.84 | 13,013 | -0.22 | -4.71% |
| 6 Months | 4.06 | 6.46 | 2.50 | 4.36 | 22,347 | 0.39 | 9.61% |
| 1 Year | 7.21 | 8.61 | 2.4603 | 5.28 | 65,502 | -2.76 | -38.28% |
| 3 Years | 35.07 | 84.00 | 2.4603 | 58.43 | 395,532 | -30.62 | -87.31% |
| 5 Years | 36.05 | 133.70 | 2.4603 | 54.08 | 412,582 | -31.60 | -87.66% |
Edesa Biotech Description
| Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. |
